Based on their findings, the researchers suggest a potential need for screening for coexisting sleep disorder symptoms in ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Fexagratinib targets FGF, CSF, and VEGF pathways, showing potential in MS treatment by reducing inflammation and promoting ...

The venetoclax-based regimen was associated with an approximate $8000 decrease in costs compared with the continuous Bruton ...

Objectives: We assessed whether proactive care management for artificial intelligence (AI)–identified at-risk patients reduced preventable emergency department (ED) visits and hospital ...

A total of 7 states passed ballot measures during the 2024 presidential election to enshrine abortion access into their state ...

Obe-cel is the first FDA-approved CAR T-cell therapy for B-ALL without a REMS requirement, based on the FELIX trial's ...

As Cigna and Humana pick back up on the potential for a megamerger, executives will be keeping a close eye on the outcomes of ...

The Quadruple Aim—a framework originally rooted in improving patient experience, enhancing population health, and achieving ...

The complex relationship between possibly impaired cognitive function in patients with multiple sclerosis (MS) and fasting ...

A new drug application (NDA) has been submitted to the FDA for sunvozertinib in pretreated EGFR exon 20–positive advanced non ...

Inteleclinic AI tool automates neuromuscular exam scoring, reducing time and ensuring consistent assessments across settings.